#blcm

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM) Dips To New 52 Week Low

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM)

December 10th, 2018 With markets going up Bellicum Pharmaceuticals Inc finished Monday’s trading session down 1.73%, a $0.07 decrease to close on $3.97. As well as the drop in value, Bellicum Pharmaceuticals Inc hit a new 52 week low of $3.82. Bellicum Pharmaceuticals Inc bounced 8.12% between high and low. Two technical ‘scores’ for stocks to be aware…

Setting A New 52 Week Low, Bellicum Pharmaceuticals Inc (Nasdaq:BLCM) Close At $4.00

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM)

October 29th, 2018 Amidst falling markets Bellicum Pharmaceuticals Inc finished Monday’s trading session down 2.91%, a $0.12 decrease to close on $4.00. As well as the drop in value, Bellicum Pharmaceuticals Inc hit a new 52 week low of $3.92, breaking the previous low of $3.93 from earlier this month. Bellicum Pharmaceuticals Inc swung 10.20% between…

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM) Hits 52 Week Low

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM)

October 26th, 2018

Amidst falling markets Bellicum Pharmaceuticals Inc closed Friday up 0.49%, a $0.02 increase to close on $4.12. Despite ending the day higher, Bellicum Pharmaceuticals Inc hit a new 52 week low of $3.93. Bellicum Pharmaceuticals Inc swung 8.65% between high and low. Two technical ‘scores’ for companies to be wary of are the Altman Z1…

(Nasdaq:BLCM) Bellicum Pharmaceuticals Inc Dips To New 52 Week Low

Bellicum Pharmaceuticals Inc (Nasdaq:BLCM)

October 24th, 2018

Amidst falling markets Bellicum Pharmaceuticals Inc closed Tuesday up 0.40%, a $0.02 increase to close on $4.97. Despite ending the day higher, Bellicum Pharmaceuticals Inc hit a new 52 week low of $4.75, breaking the previous low of $4.88 from earlier this month. Bellicum Pharmaceuticals Inc swung 7.16% between low and high. (more…)

$BLCM 2018-08-20 : Transcripts- Edited Transcript of BLCM earnings conference call

[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”

Q2 2018 Bellicum Pharmaceuticals Inc Earnings Call

Houston Aug 21, 2018 (Thomson StreetEvents) — Edited Transcript of Bellicum Pharmaceuticals Inc earnings conference call or presentation Tuesday, August 7, 2018 at 9:00:00pm GMT

TEXT version of…

EARNING UPDATE $BLCM Bellicum Pharmaceuticals, Inc. for quarter ending q_Jun18 – Revenue grew, Margins expanded

[s2If !current_user_can(access_s2member_level0)]Please login to read the earning update on BLCM [lwa][/s2If][s2If current_user_can(access_s2member_level0)]Bellicum Pharmaceuticals, Inc. reported earnings (EPS) of -0.60 per share for the quarter ending q_Jun18. This is vis-vis -0.68 per share for the previous quarter ending q_Mar18, a growth of 11.8 %. Compared to last year same quarter (q_Dec16),…